[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=8e499fe6534541607bdd8c7cade2592d630d1a2a6964e0ac0f5f4970253e75c6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498760,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "id": 136255631,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=8e499fe6534541607bdd8c7cade2592d630d1a2a6964e0ac0f5f4970253e75c6"
    }
  },
  {
    "ts": null,
    "headline": "Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y",
    "summary": "RARE posts a narrower Q2 loss and 13% revenue growth as demand rises across all four marketed rare disease drugs.",
    "url": "https://finnhub.io/api/news?id=7617ebe77f199aa474496bd605028449a8c26e9f1a9acc352366272efc9da4d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754494980,
      "headline": "Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y",
      "id": 136238882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "RARE posts a narrower Q2 loss and 13% revenue growth as demand rises across all four marketed rare disease drugs.",
      "url": "https://finnhub.io/api/news?id=7617ebe77f199aa474496bd605028449a8c26e9f1a9acc352366272efc9da4d0"
    }
  }
]